Demographic disparities in patterns of care and survival outcomes for patients with resected gastric adenocarcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 2, 2011, Pages 223-233

  Stessin, Alexander M ^a   Sherr, David L ^b  

^a Tri Institutional MD PhD Program   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; EDUCATIONAL STATUS; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POVERTY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; SOCIOECONOMICS; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; AGED; DEMOGRAPHY; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HEALTHCARE DISPARITIES; HUMANS; MALE; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; STANDARD OF CARE; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79951603506     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0158     Document Type: Article

References (27)

1. Parkin DM, Bray F, Felay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Macdonald JS. Gastric cancer - new therapeutic options. N Engl J Med 2006;355:76-7.
3. Gastrointestinal Tumor Study Group. A comparison of combination therapy and combined modality therapy for locally advanced gastric carcinoma. Cancer 1982;49:1771-7.
4. Moertel CG, Childs DS, O'Fallon JR, Holbrook MA, Schutt AJ, Reitemeier RJ. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol 1984;2:1249-54. (Pubitemid 15202699)
5. Hermans J, Bonenkamp JJ, Boon MC, Ohyama S, Sasako M, Van de Velde CJ. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993; 11:1441-47. (Pubitemid 23228247)
6. Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomized trials. Eur J Cancer 1999; 35:1059-64. (Pubitemid 29339187)
7. Mari E, Floriani I, Tinazzi A, Buda A, Belfigio M, Valentini M, et al. Efficay of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomized trials - a study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000;11:837-43.
8. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 1994; 343:1309-12.
9. MacDonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.
10. MacDonald JS, Smalley S, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. : SWOG; ECOG; RTOG; CALGB; NCCTG. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction: update of the results of Intergroup Study INT-0116 (SWOG 9008). San Francisco, CA: ASCO; 2004.
11. Cancer Care Ontario: Gastrointestinal Cancer Evidence-based Series and Practice Guidelines. Neoadjuvant or Adjuvant Therapy for Resectable Gastric Cancer, 2008. Available at: http://www.cancercare.on.ca/.
12. NCCN Physician Guidelines for Cancer Care, 2010. Available at: http://www.nccn.org/.
13. Coburn NG, Guller U, Baxter NN, Kiss A, Ringash J, Swallow CJ, et al. Adjuvant therapy for resected gastric cancer - rapid, yet incomplete adoption following results of Intergroup 0116 Trial. Int J Radiat Oncol Biol Phys 2008;70:1073-80. (Pubitemid 351296112)
14. Kozak KR, Moody JS. The survival impact of the Intergroup 0116 trial on patients with gastric cancer. In J Radiat Oncol Biol Phys 2008;72:517-21.
15. Enestvedt CK, Diggs BS, Shipley DK, Thomas CR, Billingsley KG. A population based analysis of surgical and adjuvant therapy for resectable gastric adenocarcinoma. Chicago, IL: ASCO; 2008.
16. Cancer Information Reference File (Medical Registry Services National Dataset), 2008.
17. Schwarz RE, Zagala-Nevarez K. Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol 2002;28:214-19. (Pubitemid 35023670)
18. Gill S, Shah A, Le N, Cook EF, Yoshida EM. Asian ethnicity-related difference in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol 2003;21:2070-76. (Pubitemid 46606354)
19. Theuer CP. Ethnicity-related gastric cancer survival. J Clin Oncol 2003;21:4253.
20. Yao JC, Schnirer II, Reddy S, Chiang S, Najam A, Yu C, et al. Effects of sex and racial/ethnic group on the pattern of gastric cancer localization. Gastric Cancer 2002;5:208-12. (Pubitemid 36605883)
21. Wilkinson NW, Howe J, Gay G, Patel-Parekh L, Scott-Conner C, Donohue J. Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation. Ann Surg Oncol 2008;15:1644-50.
22. Al-Refaie WB, Tseng JF, Gay G, Patel-Parekh L, Mansfield PF, Pisters PW, et al. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base. Cancer 2008;113:461-9.
23. Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF, Thomas CR. Conditional survival in gastric cancer: a SEER based analysis. Gastric Cancer 2007;10:153-8. (Pubitemid 47547297)
24. Mailey BA, Sun C, Artinyan AC. Relative outcomes for Asian-Americans with gastric adenocarcinoma. Presented at ASCO Gastrointestinal Cancers Symposium, San Francisco; 2009.
25. Macdonald J, Smalley S, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Postoperative Combined Radiation and Chemotherapy Improves Disease-Free Survival (DFS) and Overall Survival (OS) in Resected Adenocarcinoma of the Stomach and GE Junction. Results of intergroup study INT-0116 (SWOG 9008). Proc Am Soc Clin Oncol 2000;19:1a.
26. Leong CN, Chung HT, Lee KM, Shakespeare TP, Mukherjee RK, Wong LC, et al. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Cancer J 2008;14:269-75.
27. Oechsle K, Bokemeyer C, Hartmann JT, Budach W, Trarbach T, Stahl M, et al. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ ARO/CAO group. J Cancer Res Clin Oncol 2008;135(2):163-72.